首页> 外国专利> A procedure for the preparation of new derivatives of homopirimidazol. (Machine-translation by Google Translate, not legally binding)

A procedure for the preparation of new derivatives of homopirimidazol. (Machine-translation by Google Translate, not legally binding)

机译:制备高比莫立达唑新衍生物的方法。 (通过Google翻译进行机器翻译,没有法律约束力)

摘要

A procedure for the preparation of new homopyrimidazole derivatives of the general formula **(See formula)** where R, R1, R2 and R3 represent hydrogen, alcohol, halogen, alkoxy, nitro or amino; R4 is hydrogen, alcohol, aralcohyl, aryl, = 0, alkoxy, halogen or hydroxyl; R5 is hydrogen, halogen or a group -COOH, -COO-alcoholic, -CONH2, -CORH-alcoholic, -CON (alcoholic) 2, -CH2OH, -CH2O-alcoholic or -CO-nhoh; R6 is hydrogen, alcohol, aralcohyl, aryl, = 0, alkoxy, halogen or hydroxyl; R7 is hydrogen, alcoholic, aryl or aralcohyl; and the dashed lines represent optional double bonds, which comprises reacting an amino-pyridine derivative of the general formula. **(See formula)** wherein the substituents R, R1, R2 and R3 have the same meanings as indicated above, with a compound of the general formula **(See formula)** wherein R8 is hydrogen, alcoholic, aralkoxy, aryl, = 0, alkoxy, halogen, or hydroxyl; R9 is hydrogen, alcohol, aralcohyl, aryl, halogen, a radical of a carboxylic acid or of a carboxylic acid derivative; R10 is hydrogen, alcohol, aralcohyl, aryl, = 0, alkoxy, halogen, or hydroxyl; R11 is alkoxy, = 0, hydroxyl, hydrogen or halogen; R12 is alkoxy, = 0, hydroxyl, hydrogen or halogen, and cyclize the condensation product thus obtained, if desired, after isolation, in the presence of phosphoric acid and an acidic condensation agent, whereby compounds of the general formula **(See formula)** or salts thereof (in which the R-R10 substituents have the same meanings as indicated above) and, if desired, convert the compounds thus obtained into their salts, or release the bases from their salts, or convert one salt in another, and/or, if desired, reducing a compound thus obtained, or introducing substituents R4, R5, R6 and/or R7 into the molecule, by methods known per se. (Machine-translation by Google Translate, not legally binding)
机译:通式为**的新高嘧啶衍生物的制备方法(见式)其中R,R1,R2和R3代表氢,醇,卤素,烷氧基,硝基或氨基; R4是氢,醇,芳酰基,芳基= 0,烷氧基,卤素或羟基; R5是氢,卤素或基团-COOH,-COO-醇,-CONH2,-CORH-醇,-CON(醇)2,-CH2OH,-CH2O-醇或-CO-nhoh; R6为氢,醇,芳酰基,芳基= 0,烷氧基,卤素或羟基; R7是氢,醇,芳基或芳烷基;虚线表示任选的双键,其包括使通式的氨基吡啶衍生物反应。 **(参见式)**,其中取代基R,R1,R2和R3具有与上述相同的含义,且具有通式**(参见式)**的化合物,其中R8为氢,醇,芳烷氧基,芳基,= 0,烷氧基,卤素或羟基; R9是氢,醇,芳酰基,芳基,卤素,羧酸或羧酸衍生物的基团; R10是氢,醇,芳酰基,芳基= 0,烷氧基,卤素或羟基; R11是烷氧基,= 0,羟基,氢或卤素; R 12为烷氧基,= 0,羟基,氢或卤素,并在分离后,在磷酸和酸性缩合剂的存在下,如果需要,将如此获得的缩合产物环化,从而得到通式**的化合物(见通式)**或其盐(其中R-R10取代基的含义与上述含义相同),如果需要,可将如此获得的化合物转化为其盐,或从其盐中释放碱,或将一种盐转化为另一种盐通过本身已知的方法,和/或,如果需要,还原由此获得的化合物,或将取代基R4,R5,R6和/或R7引入分子中。 (通过Google翻译进行机器翻译,没有法律约束力)

著录项

  • 公开/公告号ES363378A1

    专利类型

  • 公开/公告日1970-12-16

    原文格式PDF

  • 申请/专利号ES19690363378

  • 发明设计人

    申请日1969-02-07

  • 分类号A61K;

  • 国家 ES

  • 入库时间 2022-08-23 10:06:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号